- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02895074
Subfoveal Choroidal Thickness After Surgery for Age-related Cataracts
September 5, 2016 updated by: Haotian Lin, Sun Yat-sen University
Subfoveal Choroidal Thickness After Femtosecond Laser-assisted Cataract Surgery for Age-related Cataracts
To compare the effects of femtosecond laser-assisted cataract surgery (FLACS) and conventional phacoemulsification surgery (CPS) on subfoveal choroidal thickness (SFCT) in age-related cataracts.
Study Overview
Status
Completed
Conditions
Detailed Description
It is not clear whether femtosecond laser-assisted cataract surgery (FLACS) alters retinal and choroidal thickness.
The goal of the present study was to determine the changes of retinal and choroidal thicknesses in patients who have undergone FLACS compared to patients who have undergone conventional phacoemulsification surgery (CPS).
Study Type
Interventional
Enrollment (Actual)
40
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Guangdong
-
Guangzhou, Guangdong, China, 510060
- Zhongshan Ophthalmic Center, Sun Yat-sen University
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- ADULT
- OLDER_ADULT
- CHILD
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- The cataract stages of the patients were between N2 and N4 according to the LOCS III.
Exclusion Criteria:
- eyes with histories of ocular surgery, trauma, and ocular diseases, including diabetic retinopathy, age-related macular degeneration (AMD), high myopia, psudoexfoliation, uveitis, retinal vein occlusion, and other inflammatory and vascular retinal disorders.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: TREATMENT
- Allocation: NON_RANDOMIZED
- Interventional Model: PARALLEL
- Masking: NONE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
EXPERIMENTAL: femtosecond laser-assisted cataract surgery group
|
A femtosecond laser (Alcon-Lensx, Alcon-Lensx, Inc.) was used in this study.
After pupil dilation and topical anesthesia, the laser was docked to the eye using a curved contact lens to applanate the cornea.
With the integrated OCT imaging system, the locations of the cornea and the anterior and posterior surfaces of the crystalline lens were determined.
A 5.0-mm-diameter capsulotomy was created by scanning a cylindrical pattern and followed by lens fragmentation.
The laser was disconnected, and the remainder of the surgery was performed as phacoemulsification (Infiniti® Vision System; Alcon, USA).
Folded intraocular lenses (IOLs) were implanted in the capsular bags.
After pupil dilation, 1 drop of tropicamide (0.5%) was applied every 15 minutes for 3 applications
topical anesthesia with proparacaine hydrochloride (0.5%) was applied.
|
EXPERIMENTAL: conventional phacoemulsification surgery group
|
After pupil dilation, 1 drop of tropicamide (0.5%) was applied every 15 minutes for 3 applications
topical anesthesia with proparacaine hydrochloride (0.5%) was applied.
Phacoemulsification was performed through a temporal 3.2-mm clear corneal incision with the same machine and followed by IOLs implantation.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
The change of subfoveal choroidal thickness
Time Frame: baseline, at 1 day after surgery, 7 days after surgery, 1 month after surgery, and 3 months after surgery
|
The subfoveal choroidal thickness were measured at baseline and at 1 day, 7 days , 1 month , and 3 months postoperatively by spectral-domain optical coherence tomography.
|
baseline, at 1 day after surgery, 7 days after surgery, 1 month after surgery, and 3 months after surgery
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
The change of subfoveal retinal thickness
Time Frame: baseline, at 1 day after surgery, 7 days after surgery, 1 month after surgery, and 3 months after surgery
|
The subfoveal retinal thickness were measured at baseline and at 1 day, 7 days , 1 month , and 3 months postoperatively by spectral-domain optical coherence tomography.
|
baseline, at 1 day after surgery, 7 days after surgery, 1 month after surgery, and 3 months after surgery
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
August 1, 2014
Primary Completion (ACTUAL)
June 1, 2015
Study Completion (ACTUAL)
June 1, 2015
Study Registration Dates
First Submitted
August 29, 2016
First Submitted That Met QC Criteria
September 5, 2016
First Posted (ESTIMATE)
September 9, 2016
Study Record Updates
Last Update Posted (ESTIMATE)
September 9, 2016
Last Update Submitted That Met QC Criteria
September 5, 2016
Last Verified
September 1, 2016
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
- Eye Diseases
- Lens Diseases
- Cataract
- Physiological Effects of Drugs
- Neurotransmitter Agents
- Molecular Mechanisms of Pharmacological Action
- Central Nervous System Depressants
- Autonomic Agents
- Peripheral Nervous System Agents
- Muscarinic Antagonists
- Cholinergic Antagonists
- Cholinergic Agents
- Sensory System Agents
- Anesthetics
- Anesthetics, Local
- Mydriatics
- Proxymetacaine
- Tropicamide
Other Study ID Numbers
- CCPMOH2016-China7
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Cataract
-
Fundación Pública Andaluza para la Investigación...CompletedCataract | Cataract Mature | Cataract, Nuclear
-
Johannes Kepler University of LinzCompletedCataract Complicated | Cataract Complications OperationsAustria
-
Gemini Eye ClinicRecruitingBilateral Cataract | Unilateral CataractCzechia
-
Universitaire Ziekenhuizen KU LeuvenLaboratoires TheaRecruiting
-
Omer Othman AbdullahCompletedCongenital Cataract | Pediatric CataractIraq
-
Yonsei UniversityCompletedCataract PatientsKorea, Republic of
-
Johannes Kepler University of LinzRecruitingAphakia | Secondary Cataract Surgery | Complicated Cataract SurgeryAustria
-
National University Hospital, SingaporeSingapore General HospitalCompletedCataract Surgery | Stress Levels | Music Improving Outcomes in Cataract SurgerySingapore
-
Advanced Center for Eyecare GlobalNot yet recruiting
-
Vienna Institute for Research in Ocular SurgeryRecruiting
Clinical Trials on Femtosecond laser-assisted cataract surgery
-
Guy's and St Thomas' NHS Foundation TrustCompletedCataract | Surgery
-
University Hospital, BordeauxCompleted
-
Medical University of ViennaCompleted
-
Singapore Eye Research InstituteUnknownVisual OutcomesSingapore
-
Wenzhou Medical UniversityCompleted
-
Kenneth J RosenthalJohnson & Johnson Surgical Vision, Inc.Not yet recruitingCataract | AstigmatismUnited States
-
Steve H. Linn, ODCompletedCortical Cataract | Posterior Subcapsular Cataract | Nuclear Sclerosis of the LensUnited States
-
Technolas Perfect Vision GmbHCompletedCataractCzech Republic, India
-
Technolas Perfect Vision GmbHCompletedCataractCzech Republic, India
-
Ziemer Ophthalmic Systems AGRecruiting